How to Contribute

House bill HR2038-116

Judiciary Committee

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

• Last activity on May 15, 2019

• Introduced Apr 02, 2019

• By Rep. Meadows, Mark [R-NC-11]

Support this bill

Main Subject: Health

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.

S4796-116, HR8527-116,

Categories

Cancer Child health Child safety and welfare Congressional oversight Drug, alcohol, tobacco use Health care costs and insurance Health care coverage and access Health facilities and institutions Health personnel Health programs administration and funding Long-term, rehabilitative, and terminal care Prescription drugs Rural conditions and development Sales and excise taxes State and local finance Drug alcohol tobacco use Long-term rehabilitative and terminal care Health

House committee actions Actions

Committee
May. 15 2019	Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

House floor actions Actions

IntroReferral
Apr. 02 2019	Referred to the House Committee on the Judiciary.

Library of Congress Actions

IntroReferral
Apr. 02 2019	Introduced in House Introduced in House